NCT03931616 is a NA clinical trial of STEMO in Stroke, sponsored by Charite University, Berlin, Germany.

Who is sponsoring NCT03931616?

NCT03931616 is sponsored by Charite University, Berlin, Germany.

What drugs are being tested in NCT03931616?

Interventions in NCT03931616: STEMO, Regular care.

Is NCT03931616 still recruiting?

NCT03931616 is currently completed. Last updated 20 August 2024.

Last reviewed 2024-08-20 · How we verify

NCT03931616

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Berlin PRehospital Or Usual Delivery of Acute Stroke Care 2.0 (B_PROUD 2.0)

Completed NA Last updated 20 August 2024

What this trial tests

NA trial testing STEMO in Stroke in 1,050 participants. Completed in 28 September 2023.

Timeline

9 May 2019

Primary endpoint
31 May 2021

28 September 2023

Quick facts

Lead sponsor	Charite University, Berlin, Germany
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	1,050
Start date	9 May 2019
Primary completion	31 May 2021
Estimated completion	28 September 2023
Sites	1 location across Germany

Drugs / interventions tested

STEMO
Regular care

Conditions studied

Stroke — all drugs for Stroke →

Sponsor

Charite University, Berlin, Germany

Who can join

18 and older, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prehospital stroke care in specialized ambulances increases thrombolysis rates, reduces alarm-to-treatment times, and improves prehospital triage. Preliminary analyses suggest cost-effectiveness. However, scientific proof of improved functional outcome compared to usual care is still lacking. The objective of this trial is to show improved functional outcomes after deployment of a Stroke Emergency Mobile (STEMO) compared to regular care.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Functional stroke outcomes after mobile stroke unit deployment - the revised protocol for the Berlin Prehospital Or Usual Delivery of acute stroke care (B_PROUD) part 2 study.
Harmel P, Ebinger M, Freitag E, Grittner U, et al · · 2019 · cited 4× · PMID 33324884 · DOI 10.1186/s42466-019-0022-4
Late break abstract - 2024
· 2024
Effect of Mobile Stroke Unit Dispatch on Process Parameters and Functional Outcomes in Patients With Acute Stroke: The B_PROUD-2.0 Study.
Rohmann JL, Piccininni M, Ebinger M, Wendt M, et al · · 2025 · PMID 41100781 · DOI 10.1212/wnl.0000000000214225

Verify or expand the search:

Other trials of STEMO

Trials testing the same drug.

NCT02869386 — Berlin PRehospital Or Usual Delivery of Acute Stroke Care · NA · completed

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Charite University, Berlin, Germany trials

Trials by the same sponsor.

NCT07486167 — Influence of Lung Volume Optimization Maneuver on Cardiac Output and Lung Compliance in Ventilated Children With Congeni · Phase 1, PHASE2 · not yet recruiting
NCT07476729 — International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) · Phase 3 · not yet recruiting
NCT07503054 — Ovarian Cancer Screening and AI · NA · not yet recruiting
NCT07529197 — Observational Study on Immunoadsorption (IA) in Patients With Autoantibody-Positive Post-Infectious ME/CFS · recruiting
NCT07388693 — Feasibility of Integrating Olfactory Stimuli Into Virtual Reality Cue Exposure for Patients With Alcohol Dependence · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03931616 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Charite University, Berlin, Germany
Last refreshed: 20 August 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03931616.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing